(Q47784325)

English

Modified antigenic reactivity of anti-phospholipase A2 IgG antibodies in patients allergic to bee venom: conversion with immunotherapy and relation to subclass expression

scientific article published in July 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9679855

Modified antigenic reactivity of anti-phospholipase A2 IgG antibodies in patients allergic to bee venom: conversion with immunotherapy and relation to subclass expression (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9679855

1 reference

based on heuristic

inferred from title

author name string

A Michils

1

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9679855

M Mairesse

2

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9679855

C Ledent

3

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9679855

B Gossart

4

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9679855

S Baldassarre

5

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9679855

J Duchateau

6

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9679855

language of work or name

0 references

publication date

1 July 1998

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9679855

number of pages

9

1 reference

based on heuristic

inferred from page(s)

The Journal of Allergy and Clinical Immunology

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9679855

102

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9679855

1

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9679855

118-126

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9679855

Clinical characteristics of patients with repeated systemic reactions during specific immunotherapy with hymenoptera venoms. A retrospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970062-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical relevance of the venom-specific immunoglobulin G antibody level during immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970062-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Predictive value of venom-specific IgE, IgG and IgG subclass antibodies in patients on immunotherapy with honey bee venom.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970062-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Honeybee venom allergy: results of a sting challenge 1 year after stopping successful venom immunotherapy in 86 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970062-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Venom-specific IgG antibodies in bee and wasp allergy: lack of correlation with protection from stings.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970062-4

7 January 2021

based on heuristic

inferred from DOI database lookup

The IgE and IgG subclass antibody response in patients allergic to yellow jacket venom undergoing different regimens of venom immunotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970062-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Isotypic and idiotypic characterization of anti-bee venom phospholipase A2 antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970062-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Wasp venom immunotherapy changes IgG antibody specificity

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970062-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyposensitisation to wasp venom in six hours.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970062-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Mite allergy is associated with a specific profile of IgG epitopes recognized on antigen p1 of Dermatophagoides pteronyssinus

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970062-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunotherapy in bee sting hypersensitivity. Bee venom versus wholebody extract

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970062-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Insect venom allergy: Diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970062-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Venom immunotherapy: 10 years of experience with administration of single venoms and 50 μg maintenance doses

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970062-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination of passive and active immunization in honeybee venom immunotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970062-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Should routine measurements of serum venom-specific IgG be a standard of practice in patients receiving venom immunotherapy?

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970062-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Type I skin reactivity to native and recombinant phospholipase A2 from honeybee venom is similar

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970062-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Allergy to insect stings. II. Phospholipase A: the major allergen in honeybee venom

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970062-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of the cDNA for phospholipase A2 from honeybee venom glands. The deduced amino acid sequence reveals homology to the corresponding vertebrate enzymes

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970062-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Human monoclonal or polyclonal antibodies recognize predominantly discontinuous epitopes on bee venom phospholipase A2

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970062-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Structural basis of antigenic specificity and design of new vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970062-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Serial studies on the functional affinity and heterogeneity of antibodies of different IgG subclasses to phospholipase A2 produced in response to bee-venom immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970062-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Bee venom anti-idiotypic antibody is associated with protection in beekeepers and bee sting-sensitive patients receiving immunotherapy against allergic reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970062-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Possible dual role of anti-idiotypic antibodies in combined passive and active immunotherapy in honeybee sting allergy.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970062-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Allergens of honey bee venom

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970062-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibodies to purified bee venom proteins and peptides. II. A detailed study of changes in IgE and IgG antibodies to individual bee venom antigens.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970062-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Strong serum inhibition of specific IgE correlated to competing IgG4, revealed by a new methodology in subjects from a S. mansoni endemic area

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970062-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Measurement of IgE antibodies against purified grass pollen allergens (Lol p 1, 2, 3 and 5) during immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970062-4

7 January 2021

based on heuristic

inferred from DOI database lookup

IgE and IgG antibody response to purified bee-venom antigens and peptides in four patients who had adverse reactions to immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970062-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Interleukin 4 production by CD4+ T cells from allergic individuals is modulated by antigen concentration and antigen-presenting cell type

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970062-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Allergen immunotherapy decreases interleukin 4 production in CD4+ T cells from allergic individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970062-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Bee venom immunotherapy induces a shift in cytokine responses from a TH-2 to a TH-1 dominant pattern: comparison of rush and conventional immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970062-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Venom immunotherapy modulates interleukin-4 and interferon-gamma messenger RNA expression of peripheral T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970062-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Grass pollen immunotherapy inhibits allergen-induced infiltration of CD4+ T lymphocytes and eosinophils in the nasal mucosa and increases the number of cells expressing messenger RNA for interferon-gamma.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970062-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970062-4

7 January 2021

based on heuristic

inferred from DOI database lookup

House dust mite immunotherapy results in a decrease in Der p 2-specific IFN-gamma and IL-4 expression by circulating T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970062-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Increases in IL-12 messenger RNA+ cells accompany inhibition of allergen-induced late skin responses after successful grass pollen immunotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970062-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Regulation of IgE and IgG4 responses by allergen specific T-cell clones to bee venom phospholipase A2 in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2898%2970062-4

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0091-6749(98)70062-4

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9679855

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 February 2018

http://europepmc.org/abstract/MED/9679855

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47784325&oldid=2170698033"